-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Assumes Vor Biopharma at Neutral, Announces Price Target of $9

Benzinga·11/25/2025 14:06:02
Listen to the news
Wedbush analyst Martin Fan assumes Vor Biopharma (NASDAQ:VOR) with a Neutral rating and announces Price Target of $9.